CymaBay Therapeutics - Stock Split History | CBAY
Stock split history for CymaBay Therapeutics since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
|CymaBay Therapeutics Annual Stock Splits
|CymaBay Therapeutics Quarterly Stock Splits
||Medical - Generic Drugs
CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead product candidate, arhalofenate, is being developed for the treatment of gout. CymaBay Therapeutics Inc. is based in Newark, California.